| Dec 25 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 963.59M | $ 799.07M | $ 718.65M | $ 718.67M | $ 629.50M |
| Gross Profit | $ 560.59M | $ 485.57M | $ 439.75M | $ 455.39M | $ 391.24M |
| Operating Income | $ 129.38M | $ 89.39M | $ 67.14M | $ 95.62M | $ 53.27M |
| EBITDA | $ 189.89M | $ 143.89M | $ 89.45M | $ 119.86M | $ 77.01M |
| Net Income | $ 86.47M | $ 58.39M | $ 42.51M | $ 63.99M | $ 6.21M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 102.28M | $ 72.65M | $ 76.63M | $ 85.20M | $ 102.36M |
| Total Assets | $ 1.74B | $ 1.39B | $ 1.33B | $ 1.25B | $ 1.21B |
| Total Debt | $ 541.57M | $ 467.73M | $ 480.92M | $ 448.15M | $ 483.39M |
| Net Debt | $ 439.29M | $ 395.08M | $ 404.29M | $ 362.95M | $ 381.03M |
| Total Liabilities | $ 848.71M | $ 680.68M | $ 689.85M | $ 620.32M | $ 637.14M |
| Stockholders' Equity | $ 888.61M | $ 701.88M | $ 635.70M | $ 621.59M | $ 572.51M |
| Cash Flow | |||||
| Free Cash Flow | $ 118.94M | $ 52.05M | $ 34.83M | $ 73.84M | $ 68.22M |
| Operating Cash Flow | $ 141.84M | $ 94.32M | $ 60.77M | $ 100.53M | $ 92.24M |
| Investing Cash Flow | $ -57.41M | $ -57.15M | $ -66.26M | $ -59.45M | $ -106.45M |
| Financing Cash Flow | $ -72.28M | $ -40.96M | $ 3.79M | $ -51.07M | $ 51.86M |
Embla Medical hf (GB:0FIW)
LSE:0FIW
